How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...
O n Tuesday, researchers at Stanford and Yale revealed something that AI companies would prefer to keep hidden. Four popular ...